Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Piermont Valley Acquisition Corp

CIK: 18652481 Annual ReportLatest: 2026-02-05

10-K / February 5, 2026

Piermont Valley Acquisition Corp

Overview

Piermont Valley Acquisition Corp (formerly Capitalworks Emerging Markets Acquisition Corp) is a Cayman Islands exempted company formed as a special purpose acquisition company (SPAC). Its primary objective is to complete a Business Combination with one or more operating businesses or assets.

Current status

  • No operations or operating revenue to date. The company holds cash in a trust and intends to seek a Business Combination.
  • As of the filing date, no Business Combination target had been identified.

Employees and customers

  • Employees: 1 executive officer; no full-time employees prior to a completed Business Combination.
  • Customers: None.

Financial position (highlights)

  • Trust account (as of March 31, 2025): Approximately $2,382,346 million in the Trust Account (source text indicates a likely misprint and also references per-share redemption mechanics).
  • Public redemption reference: Approximately $11.62 per public share if a liquidation/redemption occurs under the applicable terms.
  • No operating revenue to date.
  • Funding sources: Proceeds from the public offering and private placement warrants, with potential additional funding through a Forward Purchase Agreement.

Capital structure and key securities

  • Founder Shares: 5,750,000 Class B ordinary shares purchased May 12, 2021 for $25,000 total (approximately $0.004 per share).
  • IPO:
    • 23,000,000 Units sold in the initial public offering, plus a 3,000,000 Unit overallotment, at $10.00 per Unit.
    • Each Unit consists of one Class A ordinary share and one-half of one Public Warrant.
    • Public Warrants: exercisable at $11.50 per share; expire five years after a Business Combination (subject to earlier redemption or liquidation). Public Warrants become exercisable 30 days after a Business Combination is completed and an effective registration statement is in place.
  • Private Placement Warrants: 10,500,000 warrants purchased at $1.00 each, issued to the sponsor at IPO.
  • Forward Purchase Agreement (Camber Base, LLC, affiliate of Brown University):
    • Up to $20.0 million of Forward Purchase Units may be purchased at $10.00 per unit.
    • Each unit: one Forward Purchase Share and one-half Forward Purchase Warrant.
    • Forward Purchase Investor agreed not to redeem Class A ordinary shares held by them in connection with the initial Business Combination.
    • Forward Purchase Warrants exercisable to purchase one Class A ordinary share at $11.50.
    • Forward Purchase Shares are identical to IPO Class A shares but include transfer restrictions and certain registration rights.
    • Closing expected to occur substantially concurrently with the closing of the initial Business Combination; proceeds may be used for transaction consideration, transaction expenses, and post-transaction working capital.

Shareholder extensions and related redemptions

  • First extension: Deadline extended from March 3, 2023 to June 3, 2023; redemptions included 18,751,603 Class A shares redeemed at $10.51.
  • Second extension: Extended to March 3, 2025; redemptions included 3,036,666 Class A shares redeemed at $11.07.
  • Third extension: Extended to March 3, 2026; redemptions included 1,066,745 Class A shares redeemed at approximately $10.91.

Sponsorship, name change and restructuring

  • April 19–25, 2024: CEMAC Sponsor LP entered a securities purchase agreement with Vikasati Partners LLC to sell a Class B ordinary share, 3,925,000 Class A ordinary shares, and 7,605,000 private placement warrants; new directors/officers designated by Vikasati Partners were appointed.
  • February 2025: Company changed name from Capitalworks Emerging Markets Acquisition Corp to Piermont Valley Acquisition Corp.
  • July 11, 2025 (recent restructuring): Agreement among the New Sponsor, Vikasati Partners, and the Company to transfer shares and cancel 11,700,000 private placement warrants; amendments to related agreements and voting arrangements; changes in sponsor and director/officer lineup.

Nasdaq status

  • June 2024: Nasdaq notified the company of a delisting for failing to complete a Business Combination within the required 36 months. The company did not appeal the suspension.

Recent corporate actions (highlights)

  • March 1, 2023: Business Combination Agreement with Lexasure Financial Group Ltd. (later terminated March 22, 2024).
  • April 2024: Securities purchase arrangement with Vikasati Partners and appointment of new directors/officers.
  • June 2024: Nasdaq delisting notice; no appeal pursued.
  • April–July 2025: Name change and sponsor/ownership restructuring, including cancellation of certain private placement warrants.

Strategy and governance considerations

  • The company continues to pursue an initial Business Combination and may consider targets in any sector consistent with its charter and governing documents.
  • The charter anticipates that the post-transaction company would operate as a going concern and not be treated as an investment company, with the Trust Account structure and restricted investments intended to address related considerations.
  • The company has acknowledged potential conflicts of interest among sponsors, officers, and directors and has indicated that independent opinions would be sought where relevant (for example, in transactions involving affiliates).